ARPA-H GO
ARPA-H GO
ACT FOR ULTRA RARE
ULTRAGENYX PHARMACEUTICAL
ELEMENT BIOSCIENCES
ACT FOR ULTRA RARE
ENDEAVOR BIOMEDICINES
MB
The past 12 months
Clients
5
past 12 months
Filings
7
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEFood & Drug Administration (FDA)Intl Trade Administration (ITA)
Specific issues
- Advanced Research Projects Agency for Health (ARPA-H) FY27 appropriations requests
-Advocating for the funding and independence of the Advanced Research Projects Agency for Health (ARPA-H) - FY27 appropriations
n/a termination report
Ultra rare disease advocacy
- National Security Commission on Emerging Biotechnology
- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗